Given Bayer’s (BAYRY) strong performance in German markets and its advancements in agricultural biotechnology and Parkinson’s disease research, I see ...
Read More
Given Bayer’s (BAYRY) strong performance in German markets and its advancements in agricultural biotechnology and Parkinson’s disease research, I see significant growth potential for the company, making it a strong buy opportunity.